Analysis of Ureaplasma urealyticum, Chlamydia trachomatis, Mycoplasma genitalium and Neisseria gonorrhoeae infections among obstetrics and gynecological outpatients in southwest China: a retrospective study.
Chlamydia trachomatis
Mycoplasma genitalium
Neisseria gonorrhoeae
Reproductive tract infection
Ureaplasma urealyticum
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
25 Mar 2022
25 Mar 2022
Historique:
received:
17
08
2021
accepted:
08
12
2021
entrez:
26
3
2022
pubmed:
27
3
2022
medline:
31
3
2022
Statut:
epublish
Résumé
The aim of this study was to analyze the present situation of Ureaplasma urealyticum (UU), Chlamydia trachomatis (CT), Mycoplasma genitalium (MG) and Neisseria gonorrhoeae (NG) infections among obstetrics and gynecological outpatients in southwest China. A total of 3225 urogenital swabs were included in this study. All swabs were tested by RNA-based simultaneous amplification and testing (SAT) methods. Routine analysis of leucorrhea smear and drug susceptibility were performed in UU positive patients. Of these 3225 outpatients, the positive rate was 27.07% for UU, 4.99% for CT, 3.10% for MG, and 0.09% for NG. UU, CT, and MG infections were more common in women of reproductive age (aged 25-34 years), while NG infection was more prominent in women aged 30-34 years and over 40 years. Overall, the infection rate of UU was significantly higher than that of the other three infections, and UU also played a major role even in the mixed infections. 65.07% of the UU positive patients had negative results on routine leucorrhea smear analysis, and the remaining patients may have bacterial vaginitis (15.79%), fungal vaginitis (11.48%), trichomonas vaginitis (0.96%) or other vaginal inflammation (6.70%). We have observed that maternal UU infection can lead to low birth weight, neonatal pneumonia, and premature delivery. The results of the drug susceptibility test of UU showed a higher sensitivity to pristinamycin, doxycycline, tetracycline, clarithromycin, and josamycin (100%, 97.0%, 96.4%, 95.9%, and 95.3%, respectively), and lower sensitivity to ciprofloxacin and ofloxacin (2.4% and 4.7% respectively). This study could contribute to a better understanding of the current epidemiological features of UU, CT, MG, and NG among obstetrics and gynecological outpatients in southwest China, and thus facilitate to development of the more effective intervention, prevention, and treatment of reproductive tract infection.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of this study was to analyze the present situation of Ureaplasma urealyticum (UU), Chlamydia trachomatis (CT), Mycoplasma genitalium (MG) and Neisseria gonorrhoeae (NG) infections among obstetrics and gynecological outpatients in southwest China.
METHODS
METHODS
A total of 3225 urogenital swabs were included in this study. All swabs were tested by RNA-based simultaneous amplification and testing (SAT) methods. Routine analysis of leucorrhea smear and drug susceptibility were performed in UU positive patients.
RESULTS
RESULTS
Of these 3225 outpatients, the positive rate was 27.07% for UU, 4.99% for CT, 3.10% for MG, and 0.09% for NG. UU, CT, and MG infections were more common in women of reproductive age (aged 25-34 years), while NG infection was more prominent in women aged 30-34 years and over 40 years. Overall, the infection rate of UU was significantly higher than that of the other three infections, and UU also played a major role even in the mixed infections. 65.07% of the UU positive patients had negative results on routine leucorrhea smear analysis, and the remaining patients may have bacterial vaginitis (15.79%), fungal vaginitis (11.48%), trichomonas vaginitis (0.96%) or other vaginal inflammation (6.70%). We have observed that maternal UU infection can lead to low birth weight, neonatal pneumonia, and premature delivery. The results of the drug susceptibility test of UU showed a higher sensitivity to pristinamycin, doxycycline, tetracycline, clarithromycin, and josamycin (100%, 97.0%, 96.4%, 95.9%, and 95.3%, respectively), and lower sensitivity to ciprofloxacin and ofloxacin (2.4% and 4.7% respectively).
CONCLUSIONS
CONCLUSIONS
This study could contribute to a better understanding of the current epidemiological features of UU, CT, MG, and NG among obstetrics and gynecological outpatients in southwest China, and thus facilitate to development of the more effective intervention, prevention, and treatment of reproductive tract infection.
Identifiants
pubmed: 35337285
doi: 10.1186/s12879-021-06966-z
pii: 10.1186/s12879-021-06966-z
pmc: PMC8957164
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
283Subventions
Organisme : National Natural Science Foundation of China
ID : 81801628
Organisme : Key Research and Development Projects of Sichuan Science and Technology Department
ID : 2020YFS0100
Informations de copyright
© 2022. The Author(s).
Références
J Med Microbiol. 2005 Jan;54(Pt 1):23-29
pubmed: 15591251
Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):717-721
pubmed: 31832807
Ann Clin Microbiol Antimicrob. 2017 Jun 24;16(1):45
pubmed: 28646898
APMIS. 2015 Jul;123(7):586-8
pubmed: 26010780
J Virol Methods. 2014 Feb;196:139-44
pubmed: 24269796
Sex Transm Infect. 2015 Aug;91(5):308-13
pubmed: 25616607
J Matern Fetal Neonatal Med. 2014 Mar;27(4):333-7
pubmed: 23796000
BMJ Open. 2018 Nov 28;8(11):e024175
pubmed: 30498048
Sex Transm Infect. 2019 Feb;95(1):53-59
pubmed: 29925670
PLoS One. 2017 May 16;12(5):e0177842
pubmed: 28520818
BMC Pregnancy Childbirth. 2018 Jun 18;18(1):240
pubmed: 29914397
Sci Rep. 2019 Nov 4;9(1):15979
pubmed: 31685849
Curr Opin Infect Dis. 2013 Jun;26(3):231-40
pubmed: 23587772
Clin Infect Dis. 2001 Apr 1;32(7):995-1003
pubmed: 11264026
Sex Transm Infect. 2010 Apr;86(2):101-5
pubmed: 19854704
Epidemiol Infect. 2013 Dec;141(12):2650-7
pubmed: 23445723
J Clin Microbiol. 2012 Mar;50(3):646-50
pubmed: 22205804
JAMA. 2013 May 1;309(17):1793-802
pubmed: 23632723
J Microbiol Immunol Infect. 2018 Apr;51(2):220-225
pubmed: 28711440
Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L519-L524
pubmed: 30652492
mBio. 2018 Aug 7;9(4):
pubmed: 30087172